市場調查報告書
商品編碼
1423760
到 2030 年基因表現分析市場預測:按產品、技術、應用、最終用戶和地區進行的全球分析Gene Expression Analysis Market Forecasts to 2030 - Global Analysis By Product (DNA Chips, Kits & Reagents, Services and Other Products), Technology, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球基因表現分析市場規模將達49億美元,預計2030年將達到100億美元,預測期內複合年成長率為10.8%。
基因表現分析是指基因轉錄為RNA並翻譯為蛋白質的過程,或對基因編碼的功能產物的研究。測量特定條件下特定細胞、組織和生物體中基因的活性。基因表現分析有助於了解各種生物過程的分子機制,包括發育、分化、對刺激的反應和疾病。透過檢查基因表現模式,研究人員可以識別參與特定途徑的關鍵基因,揭示基因的調節方式,並深入了解疾病的分子基礎。
印度工商聯合會(FICCI)2016年的一項調查顯示,印度生物技術領域近80%的科學家擁有博士學位或博士後學位,而20%擁有碩士學位。生產人員短缺18%。
擴大個人化醫療的採用
個人化醫療的採用正在迅速增加,重點是根據個人的基因譜量身訂做治療方法。這一趨勢是由基因組研究和技術的進步所推動的,這些進步使得更準確地分析基因表現模式成為可能。隨著醫療保健提供者意識到個人化方法的價值,市場預計將進一步擴大並為客製化治療和診斷提供創新解決方案。
缺乏訓練有素的專業人員
對基因表現資料解釋和分析的熟練專業人員的需求遠遠超過目前的勞動力供應。這一不足對充分發揮基因組學在理解疾病和開發標靶治療的潛力提出了重大挑戰。透過教育和培訓計劃來彌補這一差距對於推動該領域發展並釋放基因表現分析在醫療保健和生命科學領域的變革力量至關重要。市場面臨訓練有素的專業人員嚴重短缺,阻礙了基因組研究和診斷的進步。
快速的技術進步
高通量測序、單細胞分析和基因表現了前所未有的精確度和效率水平。基因表現分析技術的不斷進步具有推進精準醫學和改變我們對基因調控的理解的巨大潛力。市場正在見證快速的技術進步,徹底改變了對細胞功能的理解。
設備高成本
基因表現分析所需的先進技術和專業設備導致其價格高昂。這種經濟障礙會限制小型實驗室和研究機構充分從事綜合基因表現研究的能力,影響該領域科學進步的整體性和進度。解決成本問題對於促進基因表現分析研究的廣泛參與和創新至關重要。設備高成本是抑制市場成長的因素。
COVID-19 的疫情對市場產生了重大影響。隨著人們對闡明病毒分子機制的興趣不斷增加,對基因表現分析工具的需求也隨之增加。然而,供應鏈中斷、實驗室關閉和研究經費減少都是挑戰。隨著重點轉向感染疾病研究,市場經歷了高峰和下滑。對於該行業的公司來說,實現遠端工作和數位解決方案已成為應對不確定性並保持發展勢頭的關鍵。
聚合酶鍊式反應 (PCR) 領域預計將成為預測期內最大的領域
聚合酶鍊式反應(PCR)部分預計將在預測期內成為最大的部分。這允許擴增特定 DNA 序列並促進靈敏且準確的基因表現分析。對個人化醫療的需求不斷成長以及基因組學的進步正在促進市場擴張。主要企業正在投資創新的 PCR 技術來增強產品系列。由於PCR在診斷、治療和研究活動中的應用不斷擴大,預計該市場將繼續成長。
藥物研發和開發領域預計在預測期內複合年成長率最高
預計藥物研發和開發領域在預測期內將出現最高的複合年成長率。研究人員利用尖端技術分析基因表現模式,以確定潛在的藥物研發標靶和生物標記。這種複雜的方法可以更深入地了解疾病機制並有助於開發創新療法。隨著基因組學和生物資訊學的不斷進步,這個市場對於塑造精準醫療和個人化治療策略的未來仍然至關重要。
預計北美在預測期內將佔據最大的市場佔有率。該地區對基因表現工具(包括微陣列和次世代定序平台)的需求強勁。市場成長的關鍵因素包括基因組學研究活動的增加、慢性病盛行率的上升以及支持性的法規環境。研究機構和產業參與者之間的合作正在進一步推動基因表現分析的創新並確保繁榮的市場形勢。
由於學術機構和生物技術公司之間的合作,預計亞太地區在預測期內將保持最高的複合年成長率。該地區的主要參與者正在積極開發基因表現分析的創新解決方案,為形成充滿活力和競爭的形勢做出貢獻。隨著該地區成為基因組和分子生物學研究的重要中心,市場的上升趨勢預計將持續。
According to Stratistics MRC, the Global Gene Expression Analysis Market is accounted for $4.9 billion in 2023 and is expected to reach $10.0 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Gene expression analysis refers to the study of the way genes are transcribed into RNA and translated into proteins, or the functional products they encode. It involves the measurement of the activity of genes in a particular cell, tissue, or organism under specific conditions. The analysis provides insights into wh Gene expression analysis for understanding the molecular mechanisms underlying various biological processes, including development, differentiation, response to stimuli, and diseases. By examining the patterns of gene expression, researchers can identify key genes involved in specific pathways, determine how genes are regulated, and gain insights into the molecular basis of diseases.
According to a 2016 survey conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), India faces an acute shortage of nearly 80% of Doctorate and Post Doctorate Scientists, a 20% shortage of people with a Master's degree, and a production staff shortage of 18% in the biotechnology sector.
Growing adoption of personalized medicine
The market is witnessing a surge in the adoption of personalized medicine, with a growing emphasis on tailoring treatments based on individual genetic profiles. This trend is driven by advancements in genomic research and technology, allowing for more precise analysis of gene expression patterns. As healthcare providers increasingly recognize the value of personalized approaches, the market is expected to expand further, offering innovative solutions for tailored therapies and diagnostics.
Shortage of trained professionals
The demand for skilled experts in interpreting and analyzing gene expression data far exceeds the current workforce supply. This shortage poses a significant challenge to harnessing the full potential of genomics in understanding diseases and developing targeted therapies. Addressing this gap through education and training initiatives is crucial to propel the field forward and unlock the transformative capabilities of gene expression analysis in healthcare and life sciences. The market faces a critical shortage of trained professionals, hindering advancements in genomic research and diagnostics.
Rapid technological advancement
Innovations in high-throughput sequencing, single-cell analysis, and bioinformatics have propelled gene expression analysis to unprecedented levels of accuracy and efficiency. The continuous evolution of gene expression analysis technologies holds immense promise for advancing precision medicine and transforming our understanding of genetic regulation. The market has witnessed rapid technological advancement, revolutionizing the understanding of cellular function.
High cost of the instruments
The sophisticated technology and specialized equipment required for gene expression analysis contribute to the elevated prices. This financial barrier may limit smaller laboratories or research facilities from fully engaging in comprehensive gene expression studies, potentially impacting the inclusivity and progress of scientific advancements in this field. Addressing cost concerns is crucial for fostering broader participation and innovation in gene expression analysis research. High cost of instruments is the factor hindering the growth of the market.
The COVID-19 pandemic has significantly impacted the market. Increased focus on understanding the virus's molecular mechanisms has driven demand for gene expression analysis tools. However, disruptions in supply chains, laboratory closures, and reduced funding for research have posed challenges. The market has witnessed both surges and declines, with shifts in priorities towards infectious disease research. Adapting to remote work and digital solutions has become crucial for companies in this sector to navigate the uncertainties and maintain momentum.
The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period
The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period. This enables amplification of specific DNA sequences, facilitating gene expression analysis with high sensitivity and precision. Increasing demand for personalized medicine and advancements in genomics contribute to market expansion. Key players are investing in innovative PCR technologies, enhancing product portfolios. The market is poised for continuous growth, propelled by the expanding applications of PCR in diagnostics, therapeutics, and research endeavors.
The drug discovery & development segment is expected to have the highest CAGR during the forecast period
The drug discovery & development segment is expected to have the highest CAGR during the forecast period. Leveraging cutting-edge technologies, researchers analyze gene expression patterns to identify potential drug targets and biomarkers. This sophisticated approach enables a deeper understanding of disease mechanisms, aiding in the development of innovative therapeutics. With continuous advancements in genomics and bioinformatics, the market remains integral to shaping the future of precision medicine and personalized treatment strategies.
North America is projected to hold the largest market share during the forecast period. The region showcases a strong demand for gene expression profiling tools, including microarrays and next-generation sequencing platforms. Key factors contributing to market growth include increasing research activities in genomics, rising prevalence of chronic diseases, and a supportive regulatory environment. Collaborations between research institutions and industry players further propel innovation in gene expression analysis, ensuring a flourishing market landscape.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the collaborations between academic institutions and biotechnology companies. . Key players in the region are actively developing innovative solutions for gene expression analysis, contributing to a dynamic and competitive landscape. The market's upward trajectory is expected to continue as the region becomes a prominent hub for genomics and molecular biology research.
Key players in the market
Some of the key players in Gene Expression Analysis market include Agilent Technologies, GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Luminex Corp., Quest Diagnostics, Inc., PerkinElmer, Inc., Takara Bio, Inc., Catalent Inc., Promega Corp., Danaher Corp., QIAGEN, Novogene Corporation and Oxford Nanopore Technologies.
In August 2023, The MinION MK1C, a new sequencer designed to be more reasonably priced and available to researchers, has been launched, according to an announcement from Oxford Nanopore Technologies. Gene expression analysis and RNA and DNA sequencing can both be done using the MinION MK1C.
In January 2023, The bioinformatics division of QIAGEN, QIAGEN Digital Insights (QDI), has just launched the QIAGEN CLC Genomics Workbench Premium, which eliminates the data-analysis bottleneck of next-generation sequencing.